Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and SMartin L. Biniossek, Oliver Schilling, Christoph Becker‐Pauly et al.|Journal of Proteome Research|2011Cited by 190
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Tunç Morova et al.|Cell Communication and Signaling|2023Cited by 12
Correction to Proteomic Identification of Protease Cleavage Sites Characterizes Prime and Non-prime Specificity of Cysteine Cathepsins B, L, and SMartin L. Biniossek, Oliver Schilling, Dorit K. Nägler et al.|Journal of Proteome Research|2011Cited by 2
Epigenetic-focused CRISPR/Cas9 screen identifies ASH2L as a regulator of glioblastoma cell survivalEzgi Ozyerli‐Goknar, Tugba Bagcı-Önder, Ezgi Yağmur Kala et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0